Subscription Required

Only paid subscribers* to Specialty Pharmacy News can access this Web portal with three years of back issues, searchable article archives and other valuable resources.

Subscribers to Specialty Pharmacy News receive

  • 12 monthly issues packed with news and strategies on this increasingly vital sector in health business, delivered First Class by U.S. Mail and electronically (optional),
  • E-News Alerts whenever important news breaks, and
  • Access to a subscriber-only Web page with:
    • Searchable archives of past articles,
    • Convenient library with PDFs of back issues,
    • Access to exclusive data from AIS’s quarterly surveys with major PBMs and health plans across the country,
    • Recent stories of interest and hot topic articles grouped for convenient reading, and
    • Regular postings from Managing Editor Angela Maas.
View a sample and get more information
June 2013

Recent Stories of Interest

From Specialty Pharmacy News - In recent years, 340B pricing has grown in profile on health plans’ radar screens as more hospitals purchase smaller physician offices and as providers shift patients to outpatient hospital facilities, where care often costs twice as much as the same service provided in a community practice. Entities participating in the 340B program purchase drugs at deeply discounted rates and can treat all patients, both insured and uninsured, with those cheaper drugs — but then bill plans at higher contracted rates. But it’s not only plans that are concerned with the 340B program. Read more

When P4 Healthcare LLC launched its first clinical pathways program with CareFirst… Read more

The New York Medicaid program has undergone various changes over the past… Read more

Although clinical pathways for certain cancers are growing in popularity among health… Read more

From the Editor

Welcome to your Specialty Pharmacy News subscriber-only Web page

Be sure to visit often, for PDFs of issues, archives of articles and data, and more!

Please e-mail me with your comments on the last issue of Specialty Pharmacy News, story ideas for future issues, or any other suggestions you have that can make the newsletter more useful for you.

June 17, 2013
SCOTUS Rules on FTC v. Actavis

SCOTUS reverses court decision in pay-for-delay case, says FTC complaint should not have been dismissed and claim can go forward http://tinyurl.com/mm5x4cv

March 27, 2013
FDA Approves New Biogen MS Drug

FDA approves new Biogen Idec multiple sclerosis oral therapy Tecfidera (dimethyl fumarate) as first-line treatment http://tinyurl.com/boeawyr

February 22, 2013
FDA OK’s Metastatic Breast Cancer Drug

FDA approves new Genentech drug for HER2-positive metastatic breast cancer. Kadcyla is the first antibody-drug conjugate for this indication to receive FDA approval. http://tinyurl.com/adnurso

Updated Regularly

Featured Hot Topics

It's quick and easy to sign up for FREE access to AISHealth.com!

Why do I need to register?